These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35363362)

  • 1. Asprosin, visfatin and subfatin as new biomarkers of obesity and metabolic syndrome.
    Ugur K; Erman F; Turkoglu S; Aydin Y; Aksoy A; Lale A; Karagöz ZK; Ugur I; Akkoc RF; Yalniz M
    Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2124-2133. PubMed ID: 35363362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subfatin and asprosin, two new metabolic players of polycystic ovary syndrome.
    Deniz R; Yavuzkir S; Ugur K; Ustebay DU; Baykus Y; Ustebay S; Aydin S
    J Obstet Gynaecol; 2021 Feb; 41(2):279-284. PubMed ID: 32608281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.
    Filippatos TD; Derdemezis CS; Kiortsis DN; Tselepis AD; Elisaf MS
    J Endocrinol Invest; 2007 Apr; 30(4):323-6. PubMed ID: 17556870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of regular exercise on the levels of subfatin and asprosin: a trial with different types of exercise.
    Akbulut T; Cinar V; Ugur K; Yardim M; Karagoz ZK; Aydin S
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(8):2683-2691. PubMed ID: 35503613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome.
    Kolsgaard ML; Wangensteen T; Brunborg C; Joner G; Holven KB; Halvorsen B; Aukrust P; Tonstad S
    Scand J Clin Lab Invest; 2009; 69(8):858-64. PubMed ID: 19929281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome.
    Olszanecka-Glinianowicz M; Kocełak P; Nylec M; Chudek J; Zahorska-Markiewicz B
    Arch Med Sci; 2012 May; 8(2):214-8. PubMed ID: 22661992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory evidence on a direct correlation between acute central serous chorioretinopathy and tenascin C, metalloprotein 1, BAX, BCL2, subfatin and asprosin.
    Celik F; Coteli E; Gul FC; Ozsoy E; Kobat SG; Akkoc RF; Yardim M; Sahin I; Yalcin MH; Aydin S
    J Fr Ophtalmol; 2022 Mar; 45(3):314-322. PubMed ID: 35123814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome.
    Hong T; Li JY; Wang YD; Qi XY; Liao ZZ; Bhadel P; Ran L; Yang J; Yan B; Liu JH; Xiao XH
    Int J Endocrinol; 2021; 2021():6622129. PubMed ID: 33747078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of asprosin and subfatin for differential diagnosis of serous ovarian tumors.
    Mirzaoglu M; Yavuzkir S; Mirzaoglu C; Yurt N; Dagli AF; Ozcan Yildirim S; Sahin İ; Aydin S
    Biotech Histochem; 2023 Feb; 98(2):140-146. PubMed ID: 36281766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oxygen saturation on the hypoxia-inducible factor-1α, subfatin, asprosin, irisin, c-reactive protein, maresin-1, and diamine oxidase in diabetic patients with COVID-19.
    Karaca Karagoz Z; Aydin S
    Eur Rev Med Pharmacol Sci; 2022 Dec; 26(24):9489-9501. PubMed ID: 36591859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome.
    Jialal I; Devaraj S; Kaur H; Adams-Huet B; Bremer AA
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E514-7. PubMed ID: 23303213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between visfatin and some clinical and biochemical parametres in peritoneal dialysis patients.
    Soyoral YU; Erkoc R; Begenik H; Aldemir MN; Kucukoglu ME
    J Pak Med Assoc; 2012 Nov; 62(11):1179-83. PubMed ID: 23866406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum visfatin levels in a group of Egyptian obese individuals.
    Reda R; Shehab A; Soliman D; Gabr A; Abbass A
    Egypt J Immunol; 2011; 18(1):25-32. PubMed ID: 23082477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum visfatin levels and metabolic syndrome criteria in obese female subjects.
    de Luis DA; Aller R; Gonzalez Sagrado M; Conde R; Izaola O; de la Fuente B
    Diabetes Metab Res Rev; 2013 Oct; 29(7):576-81. PubMed ID: 23704051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of visfatin levels in obese subjects.
    Kamińska A; Kopczyńska E; Bronisz A; Zmudzińska M; Bieliński M; Borkowska A; Tyrakowski T; Junik R
    Endokrynol Pol; 2010; 61(2):169-73. PubMed ID: 20464702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
    Özalp Kızılay D; Şen S; Ersoy B
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparison of serum vaspin and visfatin concentrations in obese and normal weight women.
    Saboori S; Hosseinzadeh-Attar MJ; Yousefi Rad E; Hosseini M; Mirzaei K; Ahmadivand Z
    Diabetes Metab Syndr; 2015; 9(4):320-3. PubMed ID: 25470626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.